SEC Form 4 · accession 0001179110-17-001518
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen R Fussell
Officer — Executive Vice President
Period of report
Jan 31, 2017
Accepted (ET)
Feb 2, 2017 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jan 31, 2017 | P | 12,200 | $40.77 | A | 167,167 | D | |
| Common shares without par valueF1 | holding | — | — | — | 1,486 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 53 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2017.
- F2The reporting person disclaims beneficial ownership of all securities held by his spouse.
Remarks
This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).